Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters-Reference-Cited by-同舟云学术

Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters

Published:2002-05 Issue:1-2 Volume:290 Page:35-43
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Huber Reid M,Murphy Kathleen,Miao Bowman,Link John R,Cunningham Mark R,Rupar Mark J,Gunyuzlu Paul L,Haws Thomas F,Kassam Altaf,Powell Francoise,Hollis Gregory F,Young Peter R,Mukherjee Ranjan,Burn Timothy C

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference28 articles.

1. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster;Arbeeny;J. Lipid Res.,1992

2. Autoregulation of glucocorticoid receptor gene expression;Burnstein;Steroids,1991

3. “Don't know much bile-ology”;Chawla;Cell,2000

4. Identification of a nuclear receptor that is activated by farnesol metabolites;Forman;Cell,1995

5. A novel method for real time quantitative RT-PCR;Gibson;Genome Res.,1996

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications;Acta Pharmaceutica Sinica B;2024-08

2. Loss of the DNA-binding domain of the farnesoid X receptor gene causes severe liver and kidney injuries;Biochemical and Biophysical Research Communications;2024-08

3. Activation of farnesoid X receptor retards expansion of renal collecting duct cell-derived cysts via inhibition of CFTR-mediated Cl^– secretion;American Journal of Physiology-Renal Physiology;2024-04-01

4. Palm-based tocotrienol-rich fraction (TRF) supplementation modulates cardiac sod1 expression, fxr target gene expression, and tauro-conjugated bile acid levels in aleptinemic mice fed a high-fat diet;Genes & Nutrition;2024-02-27

5. Patented Farnesoid X receptor modulators: a review (2019 – present);Expert Opinion on Therapeutic Patents;2024-02-26